B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 17
- −1 vs. Q4 2024
- Portfolio value
- $115.1M
- −$48.5M (−29.7%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ADMAAdma Biologics, Inc. | COM | 2,317,542 | $46.0M | 40.0% | +30,000+1.3% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 262,500 | $20.0M | 17.4% | −87,500−25.0% | Reduced | History |
| ZLABZai Lab Ltd | ADR | 400,000 | $14.5M | 12.6% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 242,500 | $9.82M | 8.5% | −17,500−6.7% | Reduced | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,500,000 | $5.00M | 4.3% | +508,000+51.2% | Added | History |
| CLLSCellectis S.A. | SPON ADS | 3,256,501 | $4.04M | 3.5% | +175,000+5.7% | Added | History |
| AURAAura Biosciences, Inc. | COM | 472,576 | $2.77M | 2.4% | 00.0% | Unchanged | History |
| SGHTSight Sciences, Inc. | COM | 833,600 | $2.00M | 1.7% | +204,230+32.4% | Added | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 200,000 | $1.91M | 1.7% | +149,349+294.9% | Added | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,255,556 | $1.75M | 1.5% | +290,000+30.0% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 47,500 | $1.72M | 1.5% | +39,904+525.3% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 15,000 | $1.37M | 1.2% | +11,500+328.6% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 70,000 | $1.13M | 1.0% | +20,000+40.0% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 30,000 | $1.12M | 1.0% | +15,000+100.0% | Added | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 19,000 | $719.5K | 0.6% | +19,000 | New | History |
| ETNB89bio, Inc. | COM | 95,623 | $695.2K | 0.6% | +95,623 | New | History |
| ORKAOruka Therapeutics, Inc. | COM | 58,215 | $597.3K | 0.5% | +38,215+191.1% | Added | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Ultragenyx Pharmaceutical IN90400D908 | CALL | – | $1.36M |
| Corvus Pharmaceuticals Inc221015950 | PUT | $286.2K | – |
Sold out since Q4 2024 (3)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| Invesco QQQ Tr46090E953 | PUT | 110,000 | $56.2M | 34.4% | – |
| Ultragenyx Pharmaceutical IN90400D908 | CALL | 29,500 | $1.24M | 0.8% | – |
| Corvus Pharmaceuticals Inc221015950 | PUT | 100,000 | $535.0K | 0.3% | – |